A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium

Gynecologic Oncology

Volumn 122, Issue 1, 2011, Pages 59-62

  Wrenn, Dené C ^a   Saigal, Kunal ^a   Lucci III, Joseph A ^a   Pearson, Matthew J ^a   Simpkins, Fiona ^a   Schuman, Samer ^a   Twiggs, Leo B ^a   Walker, Gail R ^b   Wolfson, Aaron H ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

Abdominal radiation; Chemopotentiator; Cisplatin; Endometrial cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ABDOMINAL RADIOTHERAPY; ADULT; AGED; BLOOD TOXICITY; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOREDUCTIVE SURGERY; DRUG DOSE REGIMEN; DRUG TOLERABILITY; ENDOMETRIUM CARCINOMA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; HYPOMAGNESEMIA; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; TREATMENT FAILURE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOSE FRACTIONATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; PACLITAXEL;

EID: 79957696829     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.03.007     Document Type: Conference Paper

References (14)

1. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK (eds). SEER Cancer Statistics Review, 1975-2007, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2. Creasman WT. Adenocarcinoma of the uterus. In: DiSaia PJ, Creasman WT, editors. Clinical Gynecologic Oncology. 7th ed. Philadelphia: Elsevier; 2008. p. 147-84.
3. Fader AN, Boruta D, Olawaiye AB, Gehrig PA. Uterine papillary serous carcinoma: epidemiology, pathogenesis, and management. Curr Opin Obstet Gynecol 2010;22:21-9.
4. Sutton G, Axelrod JH, Bundy BN, Roy T, Homesley HD, Malfetano JH. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a Gynecologic Oncology Group study. Gynecol Oncol 2005;97:755-63. (Pubitemid 40824643)
5. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, Thigpen JT, Benda JA. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecolgic Oncology Group study. J Clin Oncol 2006;24:36-44. (Pubitemid 46630491)
6. Soper JT, Reisinger SA, Ashbury R, Jones E, Clarke-Pearson DL. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial. Gynecol Oncol 2004;95:95-100.
7. Chendil D, Oakes R, Alcock RA, Patel N, Mayhew C, Mohiuddin M, Gallicchio VS, Ahmed MM. Low-dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53. Cancer 2000;89:1893-900.
8. Joiner MC, Marples B, Lambin P, Short SC, Turesson I. Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys 2001;49:379-89. (Pubitemid 32123610)
9. Dey S, Spring PM, Arnold S, Valentino J, Chendil D, Regine WF, Mohiuddin M, Ahmed MM. Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin Cancer Res 2003;9:1557-65. (Pubitemid 36418414)
10. Spring PM, Arnold SM, Shajahan S, Brown B, Dey S, Lele SM, Valentino J, Jones R, Mohiuddin M, Ahmed MM. Low dose fractionated radiation potentiates the effects of taxotere in nude mice xenografts of squamous cell carcinoma of head and neck. Cell Cycle 2004;3:479-85. (Pubitemid 40278242)
11. International Federation of Gynecology and Obstetrics (FIGO) Stages-1988 revision. Gynecol Oncol 1989;35:125-7.
12. The University of Texas at Houston Graduate School of Biomedical Sciences Medical Physics Program http://www.uthgsbsmedphys.org/GS02-0154/Brachytherapy/ 01.03.03-ICRU38.pdf).
13. Collett D. Modeling Survival Data in Medical Research2nd ed. . New York: CRC Press; 2003.
14. McMeekin DS, Walker JL, Hartenbach EM, Bookman MA, Koh W. Phase I trial of the treatment of high-risk endometrial cancer with concurrent weekly paclitaxel and cisplatin and whole abdominal radiation therapy: a Gynecologic Oncology Group study.